Cleveland BioLabs is a clinical-stage biotechnology company focused on leveraging deep mechanistic understanding of apoptosis – the cell death process – in developing a strong pipeline of compounds chiefly focused on oncology applications and mitigation of radiation injury. The company’s lead compound is currently being developed as both a radiation countermeasure and a cancer treatment. Cleveland BioLabs has two operating subsidiaries, Incuron LLC and Panacela Labs, Inc., as well as strategic relationships with various entities. For more information, visit the company’s Web site at www.cbiolabs.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: